vomiting, visual disturbance and bilateral papilloedema. On direct questioning the patient noted 6 kg of weight loss in the prior six months. On referral to the acute neurosurgical service MR imaging was carried out. Following the injection of gadolinium the lesions enhanced peripherally on T1-weighted image (T1WI) with multiple smaller enhancing lesions associated with the main lesions (Figure 1a -d) . Two well-defined (3.5 cm) low signal lesions were demonstrated on T2-weighted image (T2WI), in the left frontoparietal and right occipital regions, with marked surrounding oedema ( Figure 1e ). The diffusionweighted MR sequence did not demonstrate restricted diffusion (Figure 1f ), as would be expected of a liquid abscess. 1 Chest X-ray was normal and laboratory findings were as follows: haemoglobin 12.7 g/dl, white cell count 5.9 × 10 9 /L, C-reactive protein 20 mg/L. There was no laboratory or clinical evidence of an immunocompromised state.
In view of the mass effect caused by the left fronto-parietal lesion and the uncertain diagnosis the patient underwent an emergent image-guided craniotomy and excision of the left-sided lesion. At craniotomy a hard, well-circumscribed lesion was identified with a similar colour to normal white matter. Histology confirmed cerebral tuberculoma, as evidenced by granuloma formation and a single acid-fast bacillus. Subsequent chest CT identified pulmonary TB. The patient commenced anti-tuberculous triple therapy with Rifater, moxifloxacin, pyridoxine and dexamethasone. 2 At three-month follow-up his presenting symptoms and papilloedema had resolved and he was gaining weight. Repeat MR imaging at this point demonstrated complete surgical excision of the parietal lesion and a reduction in the size of the occipital lesion with reduced oedema suggestive of a response to pharmacological therapy (Figure 2 ).
Discussion
The global incidence of TB is increasing, even in the immunocompetent population. 3 Central nervous system TB is most common in those aged below 20 years (60-70% of cases), and coexistent extra-neural TB is only reported in 50% cases, as in this case. 4 Central nervous system TB most commonly takes the form of meningeal disease (leptomeningitis or more rarely pachymeningitis) as well as the parenchymal disease described here (tuberculous granuloma ['tuberculoma'], tuberculous abscess, focal cerebritis and 'allergic' tuberculous encephalopathy) 5 . The most common clinical presentation of a tuberculoma is headache, signs of intracranial hypertension, focal neurological deficit and seizure.
Tuberculous meningitis is characterized radiologically by the triad of basal meningeal enhancement, hydrocephalus and cerebral infarction, though a range of other features are common. 5 Cerebral tuberculomas are most common at the cortico-medullary junction, especially in the frontal and parietal lobes, as they are often the result of haematogenous spread as part of miliary TB. 6 Diffusion-weighted MR is a useful adjunct in abscesses as the central portion of an abscess will demonstrate restricted diffusion however this is not the case in a true tuberculoma. 5 Follow-up imaging following appropriate antituberculous pharmacotherapy allows the response to therapy to be gauged, with the degree of contrast enhancement and surrounding oedema related to the activity within the tuberculoma. 7 A high index of clinical suspicion is required to allow rapid diagnosis of this condition in order to institute rapid treatment and avoid potentially serious neurological sequelae.
